Switching strategies to improve lipid profile and morphologic changes.

@article{Barragn2006SwitchingST,
  title={Switching strategies to improve lipid profile and morphologic changes.},
  author={Patricia Barrag{\'a}n and Cesar Fisac and Daniel Podzamczer},
  journal={AIDS reviews},
  year={2006},
  volume={8 4},
  pages={191-203}
}
Metabolic alterations and body fat changes are well-recognized limitations of protease inhibitor-based regimens. Strategies of replacing protease inhibitors with nonnucleoside reverse transcriptase inhibitors or abacavir have been shown to improve metabolic abnormalities, particularly by decreasing cholesterol and triglyceride levels, and reducing… CONTINUE READING